"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"

NCT04641780 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Major Depressive Disorder

Interventions

DRUG: Brexpiprazole

Sponsor

Otsuka Pharmaceutical, Inc., Philippines